Click on the tab to search across Lilly for additional information
The Healthcare Professional's connection to Lilly product and condition information
Search across Lilly
Select a search category, select a topic from the pull-down menu, add optional keyword(s), then click on the search button
Product:
Condition:
Byetta
®
(exenatide) injection
Capastat
®
Sulfate
(capreomycin for injection, USP)
Cialis
®
(tadalafil)
Cymbalta
®
(duloxetine hydrochloride)
Evista
®
(raloxifene HCl)
Forteo
®
(teriparatide [rDNA origin] injection)
Lilly Glucagon
(glucagon by injection [rDNA origin])
Humalog
®
(insulin lispro injection [rDNA origin])
Humalog
®
Mix50/50
(50% insulin lispro protamine suspension, 50% insulin lispro injection [rDNA origin])
Humalog
®
Mix75/25
(75% insulin lispro protamine suspension, 25% insulin lispro injection [rDNA origin])
Humulin
®
(human insulin [rDNA origin])
Humatrope
®
(somatropin [rDNA origin] for injection)
Prozac
®
(fluoxetine hydrochloride)
Quinidine Gluconate Injection, USP
ReoPro
®
(abciximab)
Seromycin
®
(cycloserine capsules, USP)
Strattera
®
(atomoxetine hydrochloride)
Symbyax
®
(olanzapine and fluoxetine hydrochloride)
Xigris
®
(drotrecogin alfa [activated])
Zyprexa
®
(olanzapine)
Acute Bipolar Mania
Adult Growth Hormone Deficiency
ADHD
Bipolar Depression
Diabetes
Diabetic Peripheral Neuropathic Pain (DPNP)
Erectile Dysfunction
Idiopathic Short Stature (ISS)
Major Depressive Disorder (MDD)
Osteoporosis
Pediatric Growth Hormone Deficiency
Schizophrenia
Severe Sepsis
Turner Syndrome
Click on the tab to search across Lilly for additional information
For Patients & Caregivers
Resources for Physicians
Professional Documents and Downloads
Patient Education Materials
Resources Page
Prescribing Information
Safety Information
Downloadable Patient Education Materials
Living a Healthy Lifestyle
View PDF (54K)
Healthy Living Through Nutrition and Fitness
View PDF (319K)
NOTE: To view or print PDF files, you must have Adobe
®
Reader
®
.
Click here
to download the free reader.
Contact Us
|
Email A Friend
|
Print This Page